Pharmaceuticals

sllldd1.JPG

Psychiatric Digital Biomarkers Market, Share & Trends Analysis Report, By Type (Wearable, Mobile based Applications, Sensors), Clinical Practice (Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive and Prognostic Psychiatric Digital Biomarkers), End Use, By Region, and Segment Forecasts, 2024-2031

The Psychiatric Digital Biomarkers Market Size is valued at USD 513.3 Mn in 2023 and is predicted to reach USD 2,879.7 Mn by the year 2031 at an 24.7% CAGR during the forecast period for 2024-2031. The global market for psychiatric digital bi...

slld67.JPG

Fragment-Based Drug Discovery Market Size, Share & Trends Analysis Report By Technique (X-ray Crystallography, Nuclear Magnetic Resonance, Surface Plasmon Resonance. and Other Screening Techniques), By Service, By End Users, Region And Segment Forecasts, 2023-2031.

The Fragment-Based Drug Discovery Market is expected to grow at a 11.0 % CAGR during the forecast period for 2023-2031. Fragment-based Drug Discovery is being used to find similar compounds like lead in drug discovery process, which is based on id...

ssddll.JPG

Electroceuticals Market Size, Share & Trends Analysis Report, By Product (Cardiac Pacemakers & Implantable Cardioverter Defibrillators, Cochlear Implants, Neuromodulators, Retinal Implants), By Type (Implantable Electroceutical Devices and Non-Invasive Electroceutical Devices), By Application, By Region, Forecasts, 2024-2031

Electroceuticals Market Size is valued at USD 19.08 billion in 2023 and is predicted to reach USD 32.40 billion by the year 2031 at a 6.94% CAGR during the forecast period for 2024-2031 Electroceuticals is a unit of medicine that uses neurobiology...

Slidelkj2.JPG

Age-related Macular Degeneration (AMD) Drugs Market Size, Share & Trends Analysis Distribution by Products (Lucentis, Eylea & Eylea HD, Vabysmo, Syfovre, Other Products), Molecules (Ranibizumab, Aflibercept, Faricimab, Pegcetoplan, Other Molecules), Type of AMD (Wet AMD, Dry AMD), Approval type (Biologic, Biosimilar) End User and Segment Forecasts, 2024-2031

Age-related Macular Degeneration (AMD) Drugs Market Size is valued at USD 9.58 Bn in 2023 and is predicted to reach USD 19.77 Bn by the year 2031 at an 9.7% CAGR during the forecast period for 2024-2031. Age-related macular degeneration is a degen...

Weight_Loss_Drugs_Market.JPG

Weight Loss Drugs Market Size, Share & Trends Analysis Report, By Drug Type (Prescription and Over-the-counter), By Application (Appetite Suppression, Fat Blocking, and Others)), By Distribution Channel, By Region, Forecasts, 2024-2031

Weight Loss Drugs Market Size is valued at USD 26.3 billion in 2023 and is predicted to reach USD 108.9 billion by the year 2031 at a 19.7% CAGR during the forecast period for 2024-2031. The weight loss drugs market is witnessing significant growt...

Slidehr.JPG

Synthetic Blood Substitute Market, Share & Trends Analysis Report, By Application (Cardiovascular Diseases, Malignant Neoplasma, Injuries, Neonatal Conditions, Organ Transplant, Maternal Condition), By End-use, By Product, By Source, By Component, By Configuration, By Region, and Segment Forecasts, 2024-2031

The Synthetic Blood Substitute Market Size is valued at USD 7.26 Bn in 2023 and is predicted to reach USD 20.75 Bn by the year 2031 at an 14.3% CAGR during the forecast period for 2024-2031. The global synthetic blood substitute industry is rapidl...

Slidesd.JPG

Catastrophic Antiphospholipid Syndrome Market Size, Share & Trends Analysis Report, By Treatment (Anticoagulants, Immunosuppressive Therapy, Plasma Exchange Therapy, Intravenous Immunoglobulin (IVIG) and Others), By End-use (Hospitals, Clinics, Others), By Region, Forecasts, 2024-2031

The Catastrophic Antiphospholipid Syndrome Market Size was valued at USD 4.38 Bn in 2023 and is predicted to reach USD 9.34 Bn by 2031 at a 10.2% CAGR during the forecast period for 2024-2031. Catastrophic antiphospholipid syndrome refers to ...